PMID: 9528676Apr 7, 1998Paper

Effects of cardiovascular drugs on ATPase activity of P-glycoprotein in plasma membranes and in purified reconstituted form

Biochimica Et Biophysica Acta
J F Rebbeor, A E Senior

Abstract

Drug interactions with P-glycoprotein (Pgp) were quantitatively assessed using ATPase assay. Two experimental systems were used, (i) plasma membranes isolated from a multidrug-resistant cell line, which contained 30% Pgp as fraction of total membrane protein, and (ii) purified reconstituted Pgp. The cardioactive drugs verapamil, quinidine, diltiazem, nifedipine, and a series of digitalis analogs, interacted directly with Pgp as shown on ATPase in both systems. Apparent affinities of drug binding were calculated. Direct competition was shown between digitoxin and verapamil. Drug-drug interaction in vivo at the level of Pgp is expected from the results. This approach seems well-suited for empirical determination of drug interactions with Pgp, and prediction of drug-drug interactions.

References

May 7, 1976·Analytical Biochemistry·O D GaskoE Racker
Jan 1, 1992·Annual Review of Cell Biology·C F Higgins
Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S V AmbudkarI Pastan
Nov 30, 1992·Biochemical and Biophysical Research Communications·I A de Lannoy, M Silverman
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·F ThiebautM C Willingham
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C Cordon-CardoJ R Bertino
Jul 14, 1989·Biochemical and Biophysical Research Communications·D M LiebermanK L Skorecki
Apr 1, 1988·Clinical Pharmacology and Therapeutics·J HungK F Ilett
Feb 15, 1987·Analytical Biochemistry·P P Van Veldhoven, G P Mannaerts
Mar 28, 1974·The New England Journal of Medicine·K M KesslerM M Reidenberg
Nov 10, 1995·The Journal of Biological Chemistry·I L UrbatschA E Senior
Feb 1, 1995·Journal of Bioenergetics and Biomembranes·G A Scarborough
Aug 18, 1995·The Journal of Biological Chemistry·I L UrbatschA E Senior
Jan 10, 1995·Archives of Biochemistry and Biophysics·I L Urbatsch, A E Senior
Dec 12, 1993·Biochimica Et Biophysica Acta·R M Wadkins, P J Houghton
Jul 1, 1994·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·B SarkadiR C Boucher
Jan 1, 1993·Annual Review of Biochemistry·M M Gottesman, I Pastan
Dec 27, 1995·FEBS Letters·A E SeniorI L Urbatsch
Jun 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U A Germann
Jun 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J M Ford
Dec 1, 1996·Journal of Bioenergetics and Biomembranes·P D RoepeF Fritz
Jan 1, 1997·International Review of Cytology·R M Wadkins, P D Roepe

❮ Previous
Next ❯

Citations

Apr 7, 2005·Molecular and Biochemical Parasitology·Laurence M ElandalloussiPeter J Smith
Sep 3, 2002·Advanced Drug Delivery Reviews·Alexander V KabanovValery Yu Alakhov
Dec 21, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·S P HämmerleH Wunderli-Allenspach
Aug 7, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Manthena V S VarmaRamesh Panchagnula
Jun 6, 2002·European Journal of Biochemistry·Katalin GodaGábor Szabó
Jan 1, 2008·Journal of Asthma and Allergy·David Axelrod, Leonard Bielory
Nov 9, 2007·Journal of Bioenergetics and Biomembranes·Saroj VelamakanniHendrik W van Veen
Mar 10, 2000·FEBS Letters·J H HooijbergH J Broxterman
Aug 7, 2009·Fundamental & Clinical Pharmacology·Mouna KanaanJules Desmeules
May 4, 2006·British Journal of Clinical Pharmacology·Mikiko ShimizuTomonori Tateishi
Oct 4, 2006·Expert Opinion on Drug Metabolism & Toxicology·Anna Seelig, Grégori Gerebtzoff
Jun 28, 2013·Journal of Chemical Information and Modeling·Ricardo J FerreiraDaniel J V A dos Santos
Jul 20, 1999·The Annals of Pharmacotherapy·M F Hebert, A Y Lam
Mar 2, 2006·Biological & Pharmaceutical Bulletin·Tamihide MatsunagaShigeru Ohmori
Apr 2, 2003·The Journal of Biological Chemistry·Tavan JanvilisriHendrik W van Veen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.